✦ LIBER ✦

A randomized trial of coenzyme Q10 in mitochondrial disorders

✍ Scribed by Elisa I. Glover; Joan Martin; Amy Maher; Rebecca E. Thornhill; Gerald R. Moran; Mark A. Tarnopolsky

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 165 KB
Volume: 42
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.21758

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short-term effects of coenzyme Q10 in pr

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo-controlled trial

✍ Maria Stamelou; Alexander Reuss; Ulrich Pilatus; Jörg Magerkurth; Petra Niklowit 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

## Abstract Mitochondrial complex I appears to be dysfunctional in progressive supranuclear palsy (PSP). Coenzyme Q~10~ (CoQ~10~) is a physiological cofactor of complex I. Therefore, we evaluated the short‐term effects of CoQ~10~ in PSP. We performed a double‐blind, randomized, placebo‐controlled,

CINRG pilot trial of coenzyme Q10 in ste

CINRG pilot trial of coenzyme Q10 in steroid-treated duchenne muscular dystrophy

✍ Christopher F. Spurney; Carolina Tesi Rocha; Erik Henricson; Julaine Florence; J 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Exercise training in mitochondrial myopa

Exercise training in mitochondrial myopathy: A randomized controlled trial

✍ Pilar Cejudo; Juan Bautista; Teodoro Montemayor; Rafael Villagómez; Luis Jiménez 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Assessment of coenzyme q10 tolerability

Assessment of coenzyme q10 tolerability in huntington's disease

✍ Dr. A. Feigin; K. Kieburtz; P. Como; C. Hickey; D. Abwender; C. Zimmerman; K. St 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

## Abstract We performed a 6‐month open‐label trial to evaluate the tolerability and efficacy of coenzyme Q10 (CoQ) in 10 patients with Huntington's disease (HD), Subjects were evaluated at baseline, 3 months, and 6 months using the HD Rating Scale (HDRS), the HD Functional Capacity Scale (HDFCS),

Effect of mitochondrial dysfunction and

Effect of mitochondrial dysfunction and oxidative stress on endogenous levels of coenzyme Q10 in human cells

✍ Hsiu-Chuan Yen; Feng-Yuan Chen; Shih-Wei Chen; Yu-Hsiang Huang; Yun-Ru Chen; Chi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB 👁 1 views

Little is known about the regulation of endogenous CoQ 10 levels in response to mitochondrial dysfunction or oxidative stress although exogenous CoQ 10 has been extensively used in humans. In this study, we first demonstrated that acute treatment of antimycin A, an inhibitor of mitochondrial complex

A randomized, controlled trial of creati

A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies

✍ M.A. Tarnopolsky; B.D. Roy; J.R. MacDonald 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 3 views

Fatigue in patients with mitochondrial cytopathies is associated with decreased basal and postactivity muscle phosphocreatine (PCr). Creatine monohydrate supplementation has been shown to increase muscle PCr and high-intensity power output in healthy subjects. We studied the effects of creatine mono